VBI Vaccines (NASDAQ:VBIV) Shares Pass Below 200-Day Moving Average of $0.61

VBI Vaccines Inc. (NASDAQ:VBIV) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.61 and traded as low as $0.56. VBI Vaccines shares last traded at $0.60, with a volume of 123,634 shares trading hands.

Analyst Upgrades and Downgrades

Separately, StockNews.com assumed coverage on shares of VBI Vaccines in a research note on Friday. They set a “sell” rating for the company.

VBI Vaccines Stock Performance

The firm has a fifty day simple moving average of $0.61 and a 200 day simple moving average of $0.61. The company has a market capitalization of $17.04 million, a PE ratio of -0.05 and a beta of 1.93.

VBI Vaccines Company Profile

VBI Vaccines Inc, a biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. The company also develops VBI-2601, an immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study to treat solid tumors; VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial; and VBI-2501 that is in preclinical trial to treat Zika virus.